PhD student Khanyisile Kgoadi, of the Institute of Infectious Disease and Molecular Medicine (IDM) received the prestigious Tata Scholarship, at the Women in Science Awards 2015 last week Thursday. The Women in Science Awards (WISA) 2015 were founded by the Department of Science and Technology in 2003 as an intervention to reward and recognise women in the sciences.
Dr. Helen Cox, Wellcome Trust Intermediate Fellow in the Division of Medical Microbiology, Department of Pathology, and Associate Member of the IDM, has been awarded the 2015 Union Scientific Prize from the International Union Against Tuberculosis and Lung Disease.
The National Research Foundation (NRF) recently recognised the work of senior researcher in the Department of Medicine Dr Grant Theron for his work in tuberculosis (TB) diagnosis and transmission, by awarding him a P rating.
A rapid, and simple to use, low-cost urine sample to test for TB at the bed-side of HIV patients both able and unable to produce sputum, reduced the TB death-rate of patients with advanced HIV. TB treatment can be initiated quicker than if diagnosed using current diagnostic tools.
Armed with an unwavering compassion for humanity Bekker’s 30 year fight, at the coalface of the TB and HIV pandemics, has led her to the governing council of the International AIDS Society (IAS), the world's largest association of HIV professionals.
A landmark study published this month in the leading medical journal, The Lancet, reports the discovery of a blood test that can predict whether someone is likely to develop tuberculosis (TB) disease, long before the disease manifests.
A team of scientists from UCT, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Tuberculosis - the bacterial lung disease - remains a leading global health problem more than a century after it was first discovered. Mohlopheni Marakalala and Hlumani Ndlovu write about their research.
Scientists at the University of Cape Town are engaged in new research in the battle against tuberculosis (TB), which has overtaken HIV/AIDS as the leading cause of death from infectious disease. According to the World Health Organisation (WHO), TB kills about 4 000 people a day.
A recent randomized controlled trial revealed that 53% more patients initiated therapy for tuberculosis (TB) after a new diagnostic tool (GeneXpert MTB/RIF) was used to screen for TB in more than 2 261 individuals in the community.